Hyperpituitarism: Clinical Trials

1 trial for Hyperpituitarism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Suspended 1

Follow Hyperpituitarism: new trials by email Literature Review of Hyperpituitarism trials Research Report on Hyperpituitarism

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ®
Octreotide acetate LAR, Sandostatin LAR ® (octreotide acetate LAR) 30 MG - Acromegaly
Phase 1SuspendedAzidus Brasil162010-03-012022-11-03

Narrower conditions

Acromegaly (1)

Broader conditions

Bone Diseases (1)  ·  Bone Diseases, Endocrine (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Endocrine System Diseases (1)  ·  Hypothalamic Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Pituitary Diseases (1)

Sponsors

Azidus Brasil (1)

Countries

Brazil (1)